Shanghai Fosun Pharmaceutical (02196): Application for registration of oxazepam tablets received approval from the National Medical Products Administration
Fosun Pharma (02196) announced that its controlling subsidiary, Hunan Dongting Pharmaceutical Co., Ltd., has produced Oxazepam...
Shanghai Fosun Pharmaceutical (02196) announced that the application for the listing registration of oxazepam tablets (hereinafter referred to as "the drug") of its controlling subsidiary, Hunan Dongting Pharmaceutical Co., Ltd., was recently approved by the National Medical Products Administration.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
